Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.015 USD | -3.33% | -3.77% | -6.42% |
05-21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.42% | 198M | |
+64.31% | 62.59B | |
-1.24% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.55% | 26.21B | |
-21.66% | 19.09B | |
+4.87% | 13.08B | |
+25.26% | 12.26B | |
+28.05% | 12.05B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- B. Riley Initiates Lineage Cell Therapeutics at Buy with $4 Price Target, Says Platform, Pipeline Currently Undervalued